SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific - Quaterly Results

13 Feb 2024 Evaluate
Net sales declined -25.95%  to  Rs. 422.05 million from Rs. 569.99 millions.The Total Profit for the quarter ended December 2023 of Rs. 45.80 millions grew from Rs.-12.25 millions Operating profit Margin for the quarter ended December 2023 improved to 92.88% as compared to -11.23% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 422.05 569.99 -25.95 1317.47 1760.90 -25.18 2226.85 2196.26 1.39
Other Income 134.44 76.23 76.36 330.05 202.29 63.16 282.42 276.43 2.17
PBIDT 92.88 -11.23 -927.07 120.82 -0.86 -14148.84 18.82 268.93 -93.00
Interest 11.45 7.17 59.69 33.36 16.46 102.67 25.13 16.10 56.09
PBDT 81.43 -18.40 -542.55 24.92 -17.32 -243.88 -6.31 252.83 -102.50
Depreciation 20.53 21.54 -4.69 68.31 67.84 0.69 91.15 95.93 -4.98
PBT 60.90 -39.94 -252.48 -43.39 -85.16 -49.05 -97.46 156.90 -162.12
TAX 15.10 -27.69 -154.53 -11.98 -40.81 -70.64 -36.66 8.91 -511.45
Deferred Tax 10.51 -13.98 -175.18 -16.57 -14.83 11.73 -30.94 5.20 -695.00
PAT 45.80 -12.25 -473.88 -31.41 -44.35 -29.18 -60.80 147.99 -141.08
Equity 498.86 498.86 0.00 498.87 498.87 0.00 498.87 496.74 0.43
PBIDTM(%) 22.01 -1.97 -1216.99 9.17 -0.05 -18892.21 0.85 12.24 -93.10

Viyash Scientific Share Price

204.15 -3.15 (-1.52%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.20
Dr. Reddys Lab 1322.95
Cipla 1309.90
Zydus Lifesciences 891.65
Lupin 2303.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×